Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout Pregnancy

Contributed by: GlobeNewswire

Tags

technology

More Like This

Mirvie RNA Platform First to Uncover Unique Molecular Signal for Babies at Risk of Severe Fetal Growth Restriction

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

Dr Lara Zibners and Thang Vo-Ta co-founded the B-Corp inspired by Lara’s experience from multiple failed IVF cycles.

Pioneering tech to address threatened miscarriage secures NIHR grant to advance clinical trials

PR Newswire associated0

Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its Drugs with ArisGlobal Solutions

PR Newswire associated0

Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety

Randox Health Launches ‘RanChip Insight 360’ – A New Era in Preventative Health Intelligence

Carnegie Mellon University is leading a multi-university team that has secured an award of up to $39.3 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop a wearable monitoring system to better identify fetal distress and its cause, enabling a safer labor and delivery experience for mothers and babies.

Carnegie Mellon Team Awarded ARPA-H Contract to Transform Care During Labor and Childbirth

PR Newswire associated0

Mindray Unveils Project 2030 and Re-writes the Future of Women's Health Ultrasound at ISUOG